Maximize on Your Brand's Visibility for 2026
The non-opioid pain therapeutics landscape is entering a pivotal moment. After decades of limited clinical progress, recent regulatory approvals, novel targets, and translational breakthroughs have created a rapidly expanding pipeline.
This summit will place your organization at the intersection of R&D leadership, innovation, and commercial opportunity.
Developing effective non-opioid therapies remains scientifically and clinically challenging. Key hurdles include translating preclinical efficacy into humans, managing the heterogeneity of chronic pain populations, mitigating high placebo responses in trials, and addressing variability in patient-reported outcomes.
Partnership allows you to demonstrate how your solutions - whether advanced biomarker assays, PRO platforms, innovative novel translational, or trial optimization technologies - directly address these challenges and accelerate clinical progression.
Conference was not overwhelmingly large which allowed for great networking.
Abbvie
(World CNS Series)
What to Expect?
Meet New Clients
With the pain therapeutics field rapidly expanding, the summit attracts a globally represented audience of biopharma leaders and clinical decision-makers. Dedicated networking opportunities and interactive sessions provide direct access to these experts to build relationships and establish your brand as trusted partners in advancing next-generation pain therapies.
Gain Actionable Market Intelligence
With emerging targets, novel mechanisms, and evolving clinical strategies, the pain space is rapidly shifting. Dedicated networking sessions and interactive discussions provide direct insight into unmet needs, trial priorities, and strategic considerations shaping non-opioid pain programs.
Showcase Your Solutions
Demonstrate how your technologies, platforms, or services accelerate development, improve trial outcomes, and address complex translational challenges. By positioning your solutions alongside leading biopharma companies and cutting-edge innovations, you can gain visibility, credibility, and strategic alignment in a rapidly growing market poised for clinical and commercial impact.
Key Services & Solutions
Our attendees from non-opioid pain therapeutics are looking for service and solution providers with capabilities in the below areas but not limited to:
1
Support with Placebo-Controlled Standardised Studies
2
Translational Human-Pain Models
3
Advanced Electrophysiology for Preclinical Accuracy
4
Biomarker Discovery Platforms for Novel Targeting Mechanisms
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Ezgi Vedat-Irikzade
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.